Introduction
Brand name: Uropod 50 mg
Manufacturer: Astemax Biotech Pvt. Ltd. / Astelab United group
Product form: Cefpodoxime proxetil 50 mg oral suspension (orange flavour)
Uropod 50 mg is a third‑generation oral cephalosporin suspension containing cefpodoxime proxetil 50 mg per 5 ml (equivalent to cefpodoxime 50 mg). It is indicated for the treatment of susceptible bacterial infections in children and adults, including:
Respiratory tract infections (tonsillitis, pharyngitis, bronchitis, community‑acquired pneumonia).
Urinary tract infections (cystitis, pyelonephritis when sensitivity permits).
Skin and soft‑tissue infections (impetigo, cellulitis, wound infections).
ENT infections (otitis media, sinusitis).
Key features
Broad‑spectrum β‑lactam antibiotic effective against many Gram‑positive and Gram‑negative organisms, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and selected enteric pathogens.
Oral suspension with orange flavour improves palatability and ensures accurate weight‑based dosing in paediatric patients.
Uropod 50 mg can be positioned as a WHO‑GMP‑oriented, paediatric‑friendly, broad‑spectrum oral suspension for general‑practice and paediatric‑infection management under rational antibiotic‑use protocols.
